“I’ll give her the best four months possible.”
Search results
Acid Media
“How perforated squares of trippy blotter paper allowed outlaw chemists and wizard-alchemists to dose the world with LSD.”
We Bought Everything Needed to Make $3 Million Worth of Fentanyl. All It Took Was $3,600 and a Web Browser.
“At the tap of a buyer’s smartphone, Chinese chemical sellers will air-ship fentanyl ingredients door-to-door to North America. Reuters purchased enough to make 3 million pills. Such deals are astonishingly easy—and reveal how drug traffickers are eluding efforts to halt the deadly trade behind the fentanyl crisis.”
The Price of Remission
“When I was diagnosed with cancer, I set out to understand why a single pill of Revlimid cost the same as a new iPhone. I’ve covered high drug prices as a reporter for years. What I discovered shocked even me.”
This Is the Hometown of San Francisco’s Drug Dealers
“A housing boom in one area of Honduras, rooted in migration to the U.S., is being fueled by drug sales in San Francisco.”
Inside Snapchat’s Teen Opioid Crisis
“Law-enforcement sources and grieving families allege that the social media giant Snapchat has helped fuel a teen-overdose epidemic across the country. Now, their parents are fighting back.”
Tripping on LSD at the Dolphin Research Lab
How a 1960s interspecies-communication experiment went haywire.
The Degradation Drug
The fact that some prescription medications can lead to impulse-control problems is nothing new. But that doesn’t change how disruptive they are to people’s lives, or the philosophical recalibrations they demand. Carl Elliott’s dive into the world of pramipexole fallout is as fascinating as it is terrifying. The longer Hannah took pramipexole, the worse her […]
What If Psychedelics’ Hallucinations Are Just a Side Effect?
“Some neuroscientists now believe that the drugs’ mental-health benefits don’t come from tripping.”
The Great Psychedelic Experiment
“Researchers mined an old drug forum and fed the entries to an AI. The result could augur a new class of psychedelic-based antidepressants.”
